Goldfarb L - Search Results

1

PET Molecular Imaging: A Holistic Review of Current Practice and Emerging Perspectives for Diagnosis, Therapeutic Evaluation and Prognosis in Clinical Oncology.

Duclos V, Iep A, Gomez L, Goldfarb L, Besson FL. Duclos V, et al. Among authors: goldfarb l. Int J Mol Sci. 2021 Apr 16;22(8):4159. doi: 10.3390/ijms22084159. Int J Mol Sci. 2021. PMID: 33923839 Free PMC article. Review.

2

Head-to-Head Comparison Between Rabbit Sign and EANM/SNMMI Criteria for the 18F-DOPA Visual Assessment of Parkinsonian Syndromes in PET/MRI: A Multiple Expert-Based and Blinded Controlled Study.

Goldfarb L, Iep A, Chawki MB, Nguyen L, Lun F, Carpentier AAN, de Recondo A, Blin J, Bourdinaud V, Morin L, Andriatsiferana H, Ferreira A, Deschiens AM, Brulon V, Comtat C, Lebon V, Besson FL. Goldfarb L, et al. Clin Nucl Med. 2023 Feb 1;48(2):112-118. doi: 10.1097/RLU.0000000000004481. Epub 2022 Nov 18. Clin Nucl Med. 2023. PMID: 36607361

3

Relevance of ¹⁸F-DOPA visual and semi-quantitative PET metrics for the diagnostic of Parkinson disease in clinical practice: a machine learning-based inference study.

Iep A, Chawki MB, Goldfarb L, Nguyen L, Brulon V, Comtat C, Lebon V, Besson FL. Iep A, et al. Among authors: goldfarb l. EJNMMI Res. 2023 Feb 13;13(1):13. doi: 10.1186/s13550-023-00962-x. EJNMMI Res. 2023. PMID: 36780091 Free PMC article.

4

FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer.

Seban RD, Assie JB, Giroux-Leprieur E, Massiani MA, Soussan M, Bonardel G, Chouaid C, Playe M, Goldfarb L, Duchemann B, Girard N, Champion L. Seban RD, et al. Among authors: goldfarb l. Ann Nucl Med. 2020 Dec;34(12):968-974. doi: 10.1007/s12149-020-01539-7. Epub 2020 Oct 18. Ann Nucl Med. 2020. PMID: 33070295

5

Late onset of nivolumab-induced severe gastroduodenitis and cholangitis in a patient with stage IV melanoma.

Cǎlugǎreanu A, Rompteaux P, Bohelay G, Goldfarb L, Barrau V, Cucherousset N, Heidelberger V, Nault JC, Ziol M, Caux F, Maubec E. Cǎlugǎreanu A, et al. Among authors: goldfarb l. Immunotherapy. 2019 Aug;11(12):1005-1013. doi: 10.2217/imt-2019-0077. Epub 2019 Jul 15. Immunotherapy. 2019. PMID: 31304833

6

Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST.

Goldfarb L, Duchemann B, Chouahnia K, Zelek L, Soussan M. Goldfarb L, et al. EJNMMI Res. 2019 Jan 29;9(1):8. doi: 10.1186/s13550-019-0473-1. EJNMMI Res. 2019. PMID: 30694399 Free PMC article.

7

Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab.

Seban RD, Assié JB, Giroux-Leprieur E, Massiani MA, Soussan M, Bonardel G, Chouaid C, Playe M, Goldfarb L, Duchemann B, Mezquita L, Girard N, Champion L. Seban RD, et al. Among authors: goldfarb l. Cancers (Basel). 2020 Aug 10;12(8):2234. doi: 10.3390/cancers12082234. Cancers (Basel). 2020. PMID: 32785166 Free PMC article.

8

Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab.

Popinat G, Cousse S, Goldfarb L, Becker S, Gardin I, Salaün M, Thureau S, Vera P, Guisier F, Decazes P. Popinat G, et al. Among authors: goldfarb l. Oncoimmunology. 2019 Mar 6;8(5):e1580128. doi: 10.1080/2162402X.2019.1580128. eCollection 2019. Oncoimmunology. 2019. PMID: 31069139 Free PMC article.

9

Secondary hypertrophic osteoarthropathy revealing a metastatic melanoma.

Laillet J, Monnet P, Goldfarb L, Belkhir R, Robert C. Laillet J, et al. Among authors: goldfarb l. Eur J Cancer. 2023 Oct;192:113247. doi: 10.1016/j.ejca.2023.113247. Epub 2023 Aug 23. Eur J Cancer. 2023. PMID: 37625239 No abstract available.

10

Evaluating appropriateness of 18F-fluciclovine PET/CT relative to standard of care imaging guidelines and the impact of ADT on positivity: a prospective study in 62 Veterans Administration patients at a single institution.

Green A, Temsah P, Goldfarb L, Sanfolippo K, Knoche E, Muzaffar R, Osman MM. Green A, et al. Among authors: goldfarb l. Nucl Med Commun. 2024 Mar 22. doi: 10.1097/MNM.0000000000001836. Online ahead of print. Nucl Med Commun. 2024. PMID: 38517329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page